Home » Newsletters » BioWorld Science

BioWorld Science

June 26, 2018

View Archived Issues

Ribomic submits IND for anti-FGF-2 candidate

Phase III EASE-2 and EASE-3 trials of empagliflozin in type 1 diabetes meet primary endpoint

Aerpio and Gossamer Bio enter exclusive license agreement for AKB-4924

Biktarvy approved in Europe for the treatment of HIV-1 infection

Phase Ib trial results for enzalutamide/CC-115 for metastatic castration-resistant prostate cancer

Aurinia expands voclosporin clinical development program

EMA validates Giapreza MAA

Pivotal phase III study of Qzytir in acute urticaria meets key endpoints

Preliminary results of phase II study of entinostat/pembrolizumab in MSS colorectal cancer

FDA approves Epidiolex for seizures associated with LGS and Dravet syndrome

FDA grants priority review to baloxavir marboxil NDA for influenza

Clinuvel files NDA for Scenesse for erythropoietic protoporphyria

ContraVir doses first subject in first-in-human study of CRV-431

Sophiris reports interim data from phase IIb study of topsalysin for prostate cancer

Cerenis completes enrollment in TARGET study of CER-001 in esophageal cancer

Pulmatrix reports topline results from phase I/Ib study of Pulmazole

AbbVie and Calibr establish T-cell therapy collaboration for cancer

FDA grants priority review to sNDA for Imbruvica with rituximab in Waldenstrom's macroglobulinemia

University of KwaZulu-Natal patents isatin derivatives

Universitaet Hamburg divulges nucleoside triphosphate prodrug antivirals

Roche, Genentech describe RIP-1 inhibitors

Merck & Co. presents HIV integrase inhibitors

EPZ-011989 demonstrates promising antitumor activity in preclinical models of epithelioid sarcoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...